Evidence map›Paper›PMID 35604468›Full record

ReviewJournal of neurology2022

Paraneoplastic neuronal intermediate filament presenting as encephalopathy and myoclonus: a case report and literature review.

Leigh Rettenmaier, Lama Abdel-Wahed, Andrew McKeon, Christopher L Groth

Abstract readCase ReportsLetterReview
In one paragraph

Review in Journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Neuronal intermediate filament autoimmunity manifesting as ataxia and peripheral neuropathy: a case report and literature review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Leigh RettenmaierDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA. lrettenmaier@bwh.harvard.edu.ORCID http://orcid.org/0000-0003-0895-0388
Lama Abdel-WahedDepartment of Neurology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.ORCID http://orcid.org/0000-0002-0493-5968
Andrew McKeonDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-6856-8143
Christopher L GrothDepartment of Neurology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.ORCID http://orcid.org/0000-0002-6228-0824

Funding

Seronegative Autoimmune Encephalopathies: Biomarker Discovery, Validation & Deep PhenotypingR01NS126227 · NINDS · MAYO CLINIC ROCHESTER · PI Andrew McKeon · 2022 to 2026
$1.9M
NINDS NIH HHS R01 NS126227
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Brain DiseasesMyoclonusParaneoplastic SyndromesAutoantibodiesHumansIntermediate FilamentsAutoantibodiesAutoimmune diseasesEncephalopathyNIFParaneoplastic syndrome

Identifiers

PMID35604468
PMCPMC9561123

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.